MS News: June 2016

Research

  1. Nerve-insulating cells more diverse than previously thought
  2. Heart monitor implant could save lives in patients with serious immune disease
  3. ANKRD55: New gene involved in Multiple Sclerosis discovered
  4. In MS, can better sleep improve cognition?
  5. PET detects neuroinflammation in multiple sclerosis
  6. Multiple Sclerosis and Fibromyalgia – is there a connection? – Patient Talk
  7. CD8 Cells after Immunological Stem Cell Reconstitutions
  8. Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
  9. Antibodies in the CSF may be secondary to damage
  10. How do cells enter the Brain?
  11. ResearchSpeak: grey matter lesions
  12. Link between gut bacteria, MS discovered
  13. Continued inflammation in SPMS – the role of antibodies to galectin-3
  14. Obesity and multiple sclerosis: Is there a causal relationship?
  15. Gut Microbiota is different in MS
  16. The autoimmune predilection: rheumatoid arthritis in MS
  17. Tracking brain atrophy in MS could become routine, thanks to software developed at UB
  18. Diet and Gut Microbiome Influences Multiple Sclerosis Disease Activity
  19. Cerebral Microbleeds May Be Linked to Disability in Multiple Sclerosis

Clinical Trials

  1. Multiple sclerosis drug metabolite appears to slow Parkinson’s disease onset: Study
  2. New Trial of Hematopoietic Stem Cell Transplant for Aggressive Multiple Sclerosis
  3. Coherus Announces Positive Phase 2b Efficacy Data on Novel Oral Therapy

Treatment News

  1. Elementary, switch or escalate, my dear Watson?
  2. #Cladribine4MS – effective disease modification for all, even (or particularly?) after Brexit
  3. NewsSpeak: ocrelizumab applications accepted by the FDA and EMA
  4. Use of Off label Drugs in Italian Centres
  5. ClinicSpeak: holistic management of multiple sclerosis
  6. Roche eyes faster approval for multiple sclerosis drug
  7. Multiple sclerosis drug Gilenya may provide a clue for new PTSD therapy news
  8. EMA accepts for review Roche’s Ocrevus MAA for relapsing multiple sclerosis & PPMS
  9. FDA Grants Priority Review to Experimental Multiple Sclerosis Drug
  10. Fingolimod (Gilenya) Seen to Promote Peripheral Nerve Regeneration in Mice, Aiding Remyelination

General News, with many thanks to Barts MS Blog

  1. PoliticalSpeak: health inequalities in Europe
  2. PoliticalSpeak: MS prevention, or not?
  3. NurseSpeak: continuing professional development or CPD
  4. GuestPost & NurseSpeak: Amy Bowen on MS Clinical Nurse Specialist Education
  5. NewsSpeak & MSLondon: London MS Specialist Network
  6. BrainHealth & ClinicSpeak: Six ways to lead a brain-healthy lifestyle
  7. ClinicSpeak: PML without immunosuppression
  8. GameSpeak & ClinicSpeak: Can we gamify MS life skills?
Conferences
  1. NeuroSpeak: calling all UK neurologists
  2. NeuroSpeak: MS Symposium Aarhus

Lifestyle

  1. MS Management: How to Gain Control
  2. 13 Tips for Getting the Best MS Care Possible

Business News

  1. Multiple Sclerosis Market Insight Report 2016 with Global API Manufacturers and Forecast to 2018

Videos

  1. Dr. Nancy Maalouf Discusses Multiple Sclerosis (MS)
  2. New Video: Science of Hope: Incorporating the patient perspective
  3. Multiple Sclerosis London patient treatment with stem cells
  4. Multiple Sclerosis: A Guide for Patients, Families, and Caregivers
  5. Meeting the Challenge of Progressive Multiple Sclerosis
  6. Treatments for multiple sclerosis
  7. Multiple Sclerosis and Related Disorders Diagnosis, Medical Management, and Rehabilitation
  8. MS – 5 minute total body stretch – Multiple Sclerosis

_____________________________________________________________________________________________
© Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2016. Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.

2 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.